1-[3-(methylamino)-3-oxopropyl]pyridazin-1-ium-4-carboxylic acid;2,2,2-trifluoroacetate
C11H12F3N3O5 — CID 154674191
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[3-(methylamino)-3-oxopropyl]pyridazin-1-ium-4-carboxylic acid;2,2,2-trifluoroacetate
1-[3-(methylamino)-3-oxopropyl]pyridazin-1-ium-4-carboxylic acid;2,2,2-trifluoroacetate (PubChem CID 154674191) has the molecular formula C11H12F3N3O5 and a molecular weight of 323.23 g/mol. Its IUPAC name is 1-[3-(methylamino)-3-oxopropyl]pyridazin-1-ium-4-carboxylic acid;2,2,2-trifluoroacetate.
Molecular Properties
| Compound Name | 1-[3-(methylamino)-3-oxopropyl]pyridazin-1-ium-4-carboxylic acid;2,2,2-trifluoroacetate |
|---|---|
| PubChem CID | 154674191 |
| Molecular Formula | C11H12F3N3O5 |
| Molecular Weight | 323.23 g/mol |
| Exact Mass | 323.07 |
| IUPAC Name | 1-[3-(methylamino)-3-oxopropyl]pyridazin-1-ium-4-carboxylic acid;2,2,2-trifluoroacetate |
| SMILES | CNC(=O)CC[n+]1ccc(C(=O)O)cn1.O=C([O-])C(F)(F)F |
| InChI | InChI=1S/C9H11N3O3.C2HF3O2/c1-10-8(13)3-5-12-4-2-7(6-11-12)9(14)15;3-2(4,5)1(6)7/h2,4,6H,3,5H2,1H3,(H-,10,13,14,15);(H,6,7) |
| InChIKey | PGDZILHOLUFOAS-UHFFFAOYSA-N |
| XLogP | -1.50 |
| TPSA | 123.30 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 22 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 323.23 |
| LogP ≤ 5 | -1.50 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 154674191 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.